A phase II study of M-azido-pyrimethamine ethane sulphonate (MZPES) in advanced, recurrent soft tissue sarcoma. An EORTC Soft Tissue and Bone Sarcoma Group Study.
Blackledge
G
G
Department of Medicine, Queen Elizabeth Hospital, Edgbaston, Birmingham, U.K.
Verweij
J
J
Fuchs
R
R
Keizer
H J
HJ
Somers
R
R
Rankin
E
E
Kerbrat
P
P
van Oosterom
A
A
Sylvester
R
R
Thomas
D
D
D000328:Adult; D000368:Aged; D001386:Azides / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011739:Pyrimethamine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012509:Sarcoma / Q000188:drug therapy*; D012983:Soft Tissue Neoplasms / Q000188:drug therapy*
D001386:Azides; C055910:3-azidopyrimethamine; D011739:Pyrimethamine